Sign up to save your podcasts
Or
Share 322 - BioTech Investment - AusBioInvest 2022 Feature Episode
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
322 - BioTech Investment - AusBioInvest 2022 Feature Episode
📺 Watch on YouTube: https://www.youtube.com/watch?v=Wv7hOIKkcxc
The latest episode of Talking HealthTech features interviews with three industry leaders who appeared at the AusBioInvest 2022 event in Perth.
Dr Nilay Thakar, Principal of ARCH Venture Partners, delves into the mind of a venture capitalist and how to build an innovative biotech company.Â
Dr Daniel Getts, Co-Founder and CEO of Myeloid Therapeutics, shares his insight into leveraging opportunities to accelerate innovation in Australia and the US.Â
Finally, Dr Arjun Goyal, Co-Founder and Managing Director of Vida Ventures, talks about translating groundbreaking science into new medicines in the 21st century.Â
The latest episode of Talking HealthTech features interviews with three industry leaders who appeared at the AusBioInvest 2022 event in Perth.
Dr Nilay Thakar, Principal of ARCH Venture Partners, delves into the mind of a venture capitalist and how to build an innovative biotech company.Â
Dr Daniel Getts, Co-Founder and CEO of Myeloid Therapeutics, shares his insight into leveraging opportunities to accelerate innovation in Australia and the US.Â
Finally, Dr Arjun Goyal, Co-Founder and Managing Director of Vida Ventures, talks about translating groundbreaking science into new medicines in the 21st century.Â
Check out the episode and full show notes here.
Loving the show? Leave us a review, and share it with someone who might get some value from it.
Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.
View all episodes
By Talking HealthTech📺 Watch on YouTube: https://www.youtube.com/watch?v=Wv7hOIKkcxc
The latest episode of Talking HealthTech features interviews with three industry leaders who appeared at the AusBioInvest 2022 event in Perth.
Dr Nilay Thakar, Principal of ARCH Venture Partners, delves into the mind of a venture capitalist and how to build an innovative biotech company.Â
Dr Daniel Getts, Co-Founder and CEO of Myeloid Therapeutics, shares his insight into leveraging opportunities to accelerate innovation in Australia and the US.Â
Finally, Dr Arjun Goyal, Co-Founder and Managing Director of Vida Ventures, talks about translating groundbreaking science into new medicines in the 21st century.Â
The latest episode of Talking HealthTech features interviews with three industry leaders who appeared at the AusBioInvest 2022 event in Perth.
Dr Nilay Thakar, Principal of ARCH Venture Partners, delves into the mind of a venture capitalist and how to build an innovative biotech company.Â
Dr Daniel Getts, Co-Founder and CEO of Myeloid Therapeutics, shares his insight into leveraging opportunities to accelerate innovation in Australia and the US.Â
Finally, Dr Arjun Goyal, Co-Founder and Managing Director of Vida Ventures, talks about translating groundbreaking science into new medicines in the 21st century.Â
Check out the episode and full show notes here.
Loving the show? Leave us a review, and share it with someone who might get some value from it.
Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here.